Me. Clouse et al., PERCUTANEOUS INTRAARTERIAL THROMBOLYSIS - ANALYSIS OF FACTORS AFFECTING OUTCOME, Journal of vascular and interventional radiology, 5(1), 1994, pp. 93-100
PURPOSE: The authors report results of high-dose thrombolytic therapy
in native arteries and vein grafts and discuss the various factors aff
ecting outcome. PATIENTS AND METHODS: In a retrospective study, the ou
tcome of 82 high-dose urokinase infusions in 76 patients was examined.
Comorbid risk factors as they relate to outcome were studied extensiv
ely with log-linear analysis. Positive thrombolytic outcome (PTO) is d
efined as complete thrombolysis of a previously occluded segment with
restoration of antegrade flow augmented by angioplasty or operative in
tervention to clear symptoms for 30 days. RESULTS: The procedure resul
ted in a PTO in 63 of 82 instances (77%). The treatment was with uroki
nase alone in 39 cases (47%) and urokinase followed by surgery in 34 (
41%), by angioplasty in four (5%), and by angioplasty in the proximal
artery and peripheral vein grafting in five (6%). All stenoses associa
ted with grafts were treated surgically. None of the following affecte
d thrombolytic outcome: age of occlusion, heparin dose, catheter type,
length or location of graft, or artery versus graft occlusion. The 30
-day mortality was 6.1%, with a procedure-related mortality rate of 2.
4%. Overall amputation rate was 18% (74% for patients in whom lysis fa
iled by 30 days). CONCLUSION: The presence of at least one runoff vess
el was the most important factor affecting outcome (PTO, 95%; P = .000
01, chi2). The most important comorbid risk factor for failed thrombol
ysis was coronary artery disease (P = .03, chi2).